PFE
Pfizer Inc
NYSE: PFE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$26.70
+1.68% today
Updated 2026-04-30
Market cap
$149.38B
P/E ratio
19.31
P/S ratio
2.39x
EPS (TTM)
$1.36
Dividend yield
6.50%
52W range
$21 – $29
Volume
38.0M
Pfizer Inc (PFE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+33.2%
Last 4 quarters
Revenue YoY growth
-1.2%
Most recent quarter
EPS YoY growth
+4.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+1.7%
2025-08-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-03 | $0.66 | +15.8% | $26.66 | $26.78 | +0.5% |
| 2025-11-04 | $0.87 | +38.1% | $23.83 | $23.79 | -0.2% |
| 2025-08-05 | $0.51 | +41.7% | $23.53 | $23.93 | +1.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.57 | $0.66 | +15.8% | $17.56B | -1.2% |
| 2025-09-30 | $0.63 | $0.87 | +38.1% | $16.65B | -5.9% |
| 2025-06-30 | $0.36 | $0.51 | +41.7% | $14.65B | +10.3% |
| 2025-03-31 | $0.67 | $0.92 | +37.3% | $13.71B | -7.8% |
| 2024-12-31 | $0.46 | $0.63 | +37.0% | $17.76B | +21.9% |
| 2024-09-30 | $0.61 | $1.06 | +73.8% | $17.70B | +31.2% |
| 2024-06-30 | $0.46 | $0.60 | +30.4% | $13.28B | +4.3% |
| 2024-03-31 | $0.34 | $0.55 | +61.8% | $14.88B | — |
| 2023-12-31 | $-0.18 | $0.10 | +155.6% | $14.57B | — |
| 2023-09-30 | $-0.50 | $-0.42 | +16.0% | $13.49B | — |
| 2023-06-30 | $0.58 | $0.67 | +15.5% | $12.73B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $2.99 | $61.8B | +-1.2% | 14 | high |
| 2027 (E) | $2.85 | $59.6B | +-3.6% | 14 | high |
| 2028 (E) | $2.95 | $60.5B | +1.5% | 14 | medium |
| 2029 (E) | $3.10 | $62.8B | +3.8% | 14 | medium |
| 2030 (E) | $3.28 | $65.5B | +4.3% | 14 | medium |
Frequently asked questions
Has Pfizer Inc beaten earnings estimates?
Pfizer Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +33.2% over the last 4 quarters.
How does PFE stock react to earnings?
PFE stock has moved an average of +0.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Pfizer Inc's revenue growth rate?
Pfizer Inc reported year-over-year revenue growth of -1.2% in its most recent quarter, with EPS growing +4.8% year-over-year.
What is the expected EPS for PFE in 2026?
Analysts expect Pfizer Inc to report EPS of $2.99 for fiscal year 2026, on revenue of $61.8B, based on estimates from 14 analysts.